4.3 Article

Gel Filtration Chromatography as a Method for Removing Bacterial Endotoxin from Antibody Preparations

期刊

BIOTECHNOLOGY PROGRESS
卷 30, 期 6, 页码 1497-1501

出版社

WILEY-BLACKWELL
DOI: 10.1002/btpr.1961

关键词

endotoxin; protein purification

向作者/读者索取更多资源

The removal of bacterial endotoxins from biological samples is critical to avoid the potentially fatal pyrogenic response possible when introduced to mammalian systems. Endotoxins have a variety of specific characteristics that can be exploited to target their isolation and subsequent removal, but one that has not been extensively characterized is their difference in size from that of monoclonal antibodies. Here, we present a study which utilizes gel filtration chromatography as a method for endotoxin removal from both aggregated and nonaggregated antibody preparations, outlining a mechanistically simple method for removal of this impurity. (c) 2014 American Institute of Chemical Engineers Biotechnol. Prog., 30:1497-1501, 2014

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Application of coupled affinity-sizing chromatography for the detection of proteolyzed HSA-tagged proteins

Anne Serdakowski London, Kunal Patel, Lisa Quinn, Martin Lemmerer

PROTEIN EXPRESSION AND PURIFICATION (2015)

Meeting Abstract Oncology

Targeting cadherin-6 (CDH6) with an antibody-drug conjugate for the treatment of ovarian and renal cancer

Scott D. Collins, Parmita Saxena, Xiao Y. Li, Yeonju Shim, Lance Ostrom, Nicholas C. Yoder, Kalli C. Catcott, Molly A. McShea, Xiuxia Sun, Sanela Bilic, William R. Tschantz, Meghan Flaherty, Keith Mansfield, Tiancen Hu, Vladimir Capka, Markus Kurz, Ivana Liric Rajlic, Anne Serdakowski London, Duc Nguyen, Rebecca Mosher, Matthew J. Meyer, Aaron Bourret, Jamal Saeh, Scott Cameron, Emma Lees, Carl U. Bialucha

CANCER RESEARCH (2016)

Article Immunology

A novel method to determine residual detergent in biological samples post endotoxin reduction treatment and evaluation of strategies for subsequent detergent removal

Anne Serdakowski London, Chietara Japutra, Kyle Planck, Michael Lihon, Andrew Anh Nguyen

INTERNATIONAL IMMUNOPHARMACOLOGY (2016)

Article Oncology

Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers

Carl U. Bialucha, Scott D. Collins, Xiao Li, Parmita Saxena, Xiamei Zhang, Clemens Durr, Bruno Lafont, Pierric Prieur, Yeonju Shim, Rebecca Mosher, David Lee Lance Ostrom, Tiancen Hu, Sanela Bilic, Ivana Liric Rajlic, Vladimir Capka, Wei Jiang, Joel P. Wagner, GiNell Elliott, Artur Veloso, Jessica C. Piel, Meghan M. Flaherty, Keith G. Mansfield, Emily K. Meseck, Tina Rubic-Schneider, Anne Serdakowski London, William R. Tschantz, Markus Kurz, Duc Nguyen, Aaron Bourret, Matthew J. Meyer, Jason E. Faris, Mary J. Janatpour, Vivien W. Chan, Nicholas C. Yoder, Kalli C. Catcott, Molly A. McShea, Xiuxia Sun, Hui Gao, Juliet Williams, Francesco Hofmann, Jeffrey A. Engelman, Seth A. Ettenberg, William R. Sellers, Emma Lees

CANCER DISCOVERY (2017)

Article Physiology

Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function

Jennifer R. Peters-Hall, Melissa L. Coquelin, Michael J. Torres, Ryan LaRanger, Busola R. Alabi, Sei Sho, Jose F. Calva-Moreno, Philip J. Thomas, Jerry W. Shay

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)

Article Cell & Tissue Engineering

Reconstituting Mouse Lungs with Conditionally Reprogrammed Human Bronchial Epithelial Cells

Ryan LaRanger, Jennifer R. Peters-Hall, Melissa Coquelin, Busola R. Alabi, Christopher T. Chen, Woodring E. Wright, Jerry W. Shay

TISSUE ENGINEERING PART A (2018)

Article Biochemical Research Methods

Endotoxin removal and prevention for pre-clinical biologics production

Anne Serdakowski London, Brendan Kerins, William R. Tschantz, Kasey Mackay

BIOTECHNOLOGY JOURNAL (2012)

Article Biochemical Research Methods

Coupled affinity and sizing chromatography: A novel in-process analytical tool to measure titer and trend Fc-protein aggregation

Martin Lemmerer, Anne Serdakowski London, Alexandra Panicucci, Cristina Gutierrez-Vargas, Michael Lihon, Philippe Dreier

JOURNAL OF IMMUNOLOGICAL METHODS (2013)

Article Engineering, Biomedical

Decellularized mice colons as models to study the contribution of the extracellular matrix to cell behavior and colon cancer progression

Busola R. Alabi, Ryan LaRanger, Jerry W. Shay

ACTA BIOMATERIALIA (2019)

Article Chemistry, Medicinal

Aryl Sulfonamide Inhibits Entry and Replication of Diverse Influenza Viruses via the Hemagglutinin Protein

Kris White, Matthew Esparza, Jue Liang, Prasanna Bhat, Jacinth Naidoo, Briana L. McGovern, Michael A. P. Williams, Busola R. Alabi, Jerry Shay, Hanspeter Niederstrasser, Bruce Posner, Adolfo Garcia-Sastre, Joseph Ready, Beatriz M. A. Fontoura

Summary: An inhibitor of the HA protein has been identified in this study, which prevents entry and replication of influenza viruses, showing potent antiviral activity against various subtypes. Important moieties for antiviral activity have been identified through synthesis of derivatives of this compound, suggesting its potential as a lead for drug development to enhance pan-subtype efficacy in combination with other influenza A virus antivirals.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging

Sara Sepe, Francesca Rossiello, Valeria Cancila, Fabio Iannelli, Valentina Matti, Giada Cicio, Matteo Cabrini, Eugenia Marinelli, Busola R. Alabi, Alessia di Lillo, Arianna Di Napoli, Jerry W. Shay, Claudio Tripodo, Fabrizio d'Adda di Fagagna

Summary: As individuals age, the expression of ACE2 in the lungs increases, making elderly individuals more susceptible to SARS-CoV-2. Telomere damage triggers DDR activation, leading to an upregulation of ACE2 and potentially increasing susceptibility to infection in the elderly.

EMBO REPORTS (2022)

Article Oncology

Molecular mechanisms underlying the development of neuroendocrine prostate cancer

Shiqin Liu, Busola Ruth Alabi, Qingqing Yin, Tanya Stoyanova

Summary: Prostate cancer is a common cancer in men in the United States and often leads to cancer-related deaths. Androgen deprivation therapy is the standard treatment for advanced prostate cancer, but some patients develop castration-resistant prostate cancer and even neuroendocrine prostate cancer. Neuroendocrine prostate cancer is characterized by the expression of neuroendocrine markers and the absence of androgen receptor, and is often associated with aggressive tumors, therapy resistance, and poor clinical outcomes.

SEMINARS IN CANCER BIOLOGY (2022)

Article Cell Biology

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer

Meghan A. Rice, Vineet Kumar, Dhanir Tailor, Fernando Jose Garcia-Marques, En-Chi Hsu, Shiqin Liu, Abel Bermudez, Vijayalakshmi Kanchustambham, Vishnu Shankar, Zintis Inde, Busola Ruth Alabi, Arvind Muruganantham, Michelle Shen, Mallesh Pandrala, Rosalie Nolley, Merve Aslan, Ali Ghoochani, Arushi Agarwal, Mark Buckup, Manoj Kumar, Catherine C. Going, Donna M. Peehl, Scott J. Dixon, Richard N. Zare, James D. Brooks, Sharon J. Pitteri, Sanjay V. Malhotra, Tanya Stoyanova

Summary: SU086 is identified as a potential treatment for advanced prostate cancer, either as a single agent or in combination with second-generation anti-androgens. It inhibits prostate cancer cell growth and decreases heat shock protein 90 (HSP90) levels, while perturbing glycolysis.

CELL REPORTS MEDICINE (2022)

暂无数据